BGMS
NASDAQBio Green Med Solution Inc.
Price$1.09-0.59 (-35.21%)
01:15 PM07:45 PM
News · 26 weeks15-50%
2025-12-142026-06-07
Mix1490d
- SEC Filings9(64%)
- Dividends2(14%)
- Other2(14%)
- Leadership1(7%)
Latest news
25 items- SECSEC Form 425 filed by Bio Green Med Solution Inc.425 - Bio Green Med Solution, Inc. (0001130166) (Subject)
- SECBio Green Med Solution Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Bio Green Med Solution, Inc. (0001130166) (Filer)
- PRBIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD.Creation of a next-generation environmental platform: The proposed transaction brings together essential safety and environmental services, with a strategic focus on regulatory-driven industries where compliance, technical expertise, and reliability are paramount, into a single, globally scalable platform.Integrated fuels, infrastructure, and environmental markets: The combined company is expected to link niche sectors of the fire safety and green waste treatment businesses that involve mandatory compliance frameworks that drive consistent demand for these products and services, providing a resilient and diversified revenue base.Supports overlap in end-customer markets. Future NRG Sdn. Bhd.
- SECSEC Form 10-Q filed by Bio Green Med Solution Inc.10-Q - Bio Green Med Solution, Inc. (0001130166) (Filer)
- SECBio Green Med Solution Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Bio Green Med Solution, Inc. (0001130166) (Filer)
- PRBIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATEKUALA LUMPUR, MALAYSIA, May 14, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ:BGMS, "BGMS" or the "Company")), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced first quarter financial results and provided a business update. Highlights of the first quarter ended March 31, 2026, or in some cases shortly thereafter, include: ●In March, trading of the Company's 6% Convertible Exchangeable Preferred Stock (listed on The Nasdaq Capital Market under the symbol "BGMSP") was suspended and a Form 25-NSE was filed with the Securities and Exchange Commission, which removed the Company's securities from lis
- SECSEC Form DEFR14A filed by Bio Green Med Solution Inc.DEFR14A - Bio Green Med Solution, Inc. (0001130166) (Filer)
- PRAterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to AdjustmentsSUMMIT, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (NASDAQ:ATER) ("Aterian" or the "Company"), a consumer products company, today announced separate transactions related to its previously announced Strategic Alternative Process. Sale of E-Commerce Brand Portfolio (the "Asset Sale") The Company has signed a definitive agreement with Trademark Global, LLC ("Trademark") for the sale of assets associated with its marquee brands: Mueller Living, PurSteam, hOmeLabs, Squatty Potty, Healing Solutions, and Photo Paper Direct. Under the terms of the purchase agreement for the Asset Sale, Trademark will acquire the worldwide business of sourcing, marketing, and selling products under th
- SECSEC Form DEF 14A filed by Bio Green Med Solution Inc.DEF 14A - Bio Green Med Solution, Inc. (0001130166) (Filer)
- SECBio Green Med Solution Inc. filed SEC Form 8-K: Other Events8-K - Bio Green Med Solution, Inc. (0001130166) (Filer)
- SECSEC Form 10-K filed by Bio Green Med Solution Inc.10-K - Bio Green Med Solution, Inc. (0001130166) (Filer)
- SECBio Green Med Solution Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Bio Green Med Solution, Inc. (0001130166) (Filer)
- PRBIO GREEN MED SOLUTION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATEKUALA LUMPUR, MALAYSIA, March 30, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. ("BGMS," the "Company" or "we," formerly Cyclacel Pharmaceuticals, Inc.) (NASDAQ:BGMS), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced fourth quarter and full year 2025 financial results and provided a business update. "2025 was a productive year for BGMS, marked by the acquisition of Fitters Sdn. Bhd., a fire safety materials and equipment company, on September 12, 2025, the liquidation of our U.K. subsidiary and the sale of our Plogosertib drug, transactions which strengthened our balance sheet. We used this momentum to
- SECBio Green Med Solution Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Bio Green Med Solution, Inc. (0001130166) (Filer)
- SECBio Green Med Solution Inc. filed SEC Form 8-K: Other Events8-K - Bio Green Med Solution, Inc. (0001130166) (Filer)
- SECSEC Form S-8 filed by Bio Green Med Solution Inc.S-8 - Bio Green Med Solution, Inc. (0001130166) (Filer)
- SECAmendment: SEC Form 10-K/A filed by Bio Green Med Solution Inc.10-K/A - Bio Green Med Solution, Inc. (0001130166) (Filer)
- INSIDERChief Executive Officer Doris Wong Sing Ee was granted 300,178 shares, increasing direct ownership by 37% to 1,111,131 units (SEC Form 4)4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)
- INSIDERChief Financial Officer Kiu Cu Seng was granted 200,000 shares (SEC Form 4)4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)
- SECSEC Form 10-Q filed by Bio Green Med Solution Inc.10-Q - Bio Green Med Solution, Inc. (0001130166) (Filer)
- SECBio Green Med Solution Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Bio Green Med Solution, Inc. (0001130166) (Filer)
- PRBio Green Med Solution Reports Third Quarter Financial Results and Provides Business UpdateKUALA LUMPUR, Malaysia, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS, NASDAQ: BGMSP; "BGMS" or the "Company" (formerly Cyclacel Pharmaceuticals, Inc.)), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced third quarter financial results and provided a business update. Highlights of the third quarter ended September 30, 2025, or in some cases shortly thereafter, include: In July, the Company implemented a one-for-fifteen reverse stock split effective on July 7, 2025 on which day the Company's common stock began trading on a split-adjusted basis in an effort to meet the share bid
- INSIDERLarge owner Ong Yee Lung acquired 467,535 shares (SEC Form 4)4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)
- INSIDERLarge owner Kua Khai Loon acquired 467,535 shares (SEC Form 4)4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)
- INSIDERLarge owner Yap Kim Choy sold $48,518 worth of shares (28,540 units at $1.70) and acquired 467,535 shares, increasing direct ownership by 1,538% to 467,535 units (SEC Form 4)4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)
BGMS FAQ
2 questionsWhere does BGMS stock trade?
Bio Green Med Solution Inc. (BGMS) is listed on NASDAQ.How can I track BGMS on Quantisnow?
Quantisnow aggregates Bio Green Med Solution Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BGMS to receive live email and push alerts on every new disclosure.